Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.

Retirees on Medicare Advantage are missing out on crucial coverage, and their health could suffer because of it.

On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (OIG) issued a Special Advisory Bulletin ...

Though the arrangement does not fit squarely within a regulatory safe harbor, and therefore technically would generate (if ...

On January 27, the US Department of Health and Human Services Office of Inspector General (OIG) issued a Special Advisory Bulletin ...

While providers aren’t required to follow OIG recommendations, a compliance program based on their guidance can spare facilities future headaches, since ...

Network adequacy remains a significant challenge for behavioral healthcare in Medicare Advantage (MA) and Medicaid managed care, according to a new report. Analysts at the Department of Health and ...

Medicare Advantage organizations may be improperly using health risk assessments to increase risk-adjusted reimbursement, according to a report HHS’ Office of Inspector General issued in September.

A recent report published by the Office of the Inspector General showed the Medicaid program pays significantly less than Medicare for drugs. The OIG compared the prices paid (including rebates) for ...

Medicare lab spending totaled $8.4 billion in 2024, up 5 percent year over year, with $3.6 billion of that spent on genetic testing, an increase of 20 percent over 2023.

A federal watchdog said Tuesday it has begun auditing nursing homes’ use of the Patient Driven Payment Model to drive skilled nursing reimbursement, and the first targeted facility is blasting the ...